NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2017
January 08, 2018 05:00 ET
|
NanoString Technologies, Inc.
SEATTLE, Jan. 08, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today provided...
NanoString and RikenGenesis Announce Partnership to Commercialize nCounter-Based Diagnostic Assays in Japan
January 04, 2018 06:00 ET
|
NanoString Technologies, Inc.
SEATTLE and TOKYO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, and...
NanoString Technologies Highlights Advances in Precision Oncology at the 59th Annual Meeting of the American Society of Hematology
December 07, 2017 16:00 ET
|
NanoString Technologies, Inc.
More than 45 Abstracts Highlight the Value of the nCounter Platform in Hematology, including 11 that Demonstrate the Potential Clinical Utility of the Lymphoma Subtyping Test Company Announces Launch...
NanoString Highlights Record Number of nCounter-Based Research Abstracts at the 2017 Annual Meeting of the Society of Immunotherapy of Cancer (SITC)
November 09, 2017 06:00 ET
|
NanoString Technologies, Inc.
45 Abstracts Demonstrate the Value of the nCounter Platform for Immuno-Oncology Research Studies Indicate the Clinical Relevance of the Tumor Inflammation Signature for Multiple Immunotherapies ...
NanoString Technologies Releases Operating Results for Third Quarter of 2017
November 02, 2017 16:01 ET
|
NanoString Technologies, Inc.
SEATTLE, Nov. 02, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported...
NanoString and the NSABP Foundation Enter into Agreement to Study Immunophenotypes in Colorectal Cancer
October 26, 2017 06:00 ET
|
NanoString Technologies, Inc.
SEATTLE and PITTSBURGH, Oct. 26, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products,...
NanoString Announces Preliminary Revenue for Third Quarter of Fiscal Year 2017
October 11, 2017 16:01 ET
|
NanoString Technologies
SEATTLE, Oct. 11, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString’s Hyb & Seq™ Enables Liquid Biopsy by the Direct Capture and Sequencing of Cell-Free DNA
September 18, 2017 06:00 ET
|
NanoString Technologies
SEATTLE, Sept. 18, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today...
NanoString to Webcast Presentation at the 2017 Morgan Stanley Global Healthcare Conference
September 07, 2017 16:00 ET
|
NanoString Technologies
SEATTLE, Sept. 07, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today...
Anthem Issues Positive Coverage Decision for NanoString’s Prosigna® Breast Cancer Assay
September 05, 2017 06:00 ET
|
NanoString Technologies
SEATTLE, Sept. 05, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today...